This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure

Heart5.10
Volume: 107, Issue: 17, Pages: 1364 - 1366
Published: Jun 4, 2021
Abstract
Over the last decade, treatment for heart failure with reduced ejection fraction (HFrEF) has advanced, with the incremental addition of novel evidence-based medical therapies. The landmark PARADIGM-HF (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) study showed that the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan was superior to enalapril in reducing risk...
Paper Details
Title
Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure
Published Date
Jun 4, 2021
Journal
Volume
107
Issue
17
Pages
1364 - 1366
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.